U07.1 G63.0 G73.7
Conditions
Interventions
Group 1: Patients after COVID-19 with persistent neuromuscular symptoms first answer standardized questionnaires and are examined neurologically and neuropyhsiologically. After 3,6,9 and 12 months the
Sponsors
Klinik für Anästhesiologie, Intensiv- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: age = 18 years, voluntary participation, written informed consent for apparative examination, fluency in German language, positive PCR test for SARS-CoV-2 within the last 6 months, >14 days free on COVID-19-symptoms or two negative PCR tests
Exclusion criteria
Exclusion criteria: participants who are unable to provide information due to language barrier, psychological or somatic reasons, single contraindications for one of the performed tests (which are then spared)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of neuromuscular symptoms after COVID-19 (based on the initial online or telephone interview and in the course of up to 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of functional and/or morphological affection of small and large nerve fibers and muscles after COVID-19 (based on neurophysiological examinations within 6 months after COVID-19 and possibly 6 months after the initial examination) | — |
Countries
Germany
Outcome results
None listed